Research & Innovation

fueled by Passion

While supporting existing assets and developing new indications to address unmet needs, our Research & Development Department is focused on three main therapeutic areas: gastroenterology, vascular disease & neuroscience disorders.
Our new strategic plan deals with next decades challenges in healthcare, leveraging opportunities in precision medicine, maximizing existing competencies in microbiome, acquiring new assets in late stage development.
We are partnering with other organizations to exploit new opportunities through big data, new technologies, and patient engagement projects.

Read More

Mutual growth, transparency and patient centricity are the values that guide our dialogue with the medical community.
Reporting an adverse event is important in order to safeguard the patients who are taking it and ensure a favourable benefit-risk balance for the population.


During COVID-19 emergency, we strived to solidify and maintain our relationships with stakeholders by supporting them through numerous initiatives across the world.

You’re entering Alfasigma global website

I agree